The aim of this study was to assess the safety and efficacy of carbon dioxide (CO2) vaginal laser therapy (CLT) compared with sham laser therapy (SLT) after 6 months of follow-up in survivors of breast cancer with GSM receiving aromatase inhibitors. Here, CYP19A1 is linked to breast carcinoma.